For the year ending 2025-12-31, ATRA has $20,235K in assets. $58,737K in debts. $8,482K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 8,482 | |||
| Short-term investments | 0 | |||
| Restricted cash | 0 | |||
| Accounts receivable | 1,253 | |||
| Inventories | 0 | |||
| Other current assets | 2,477 | |||
| Total current assets | 12,212 | |||
| Property and equipment, gross | 286 | |||
| Less accumulated depreciation and amortization | 213 | |||
| Property and equipment, net | 73 | |||
| Operating lease assets | 7,064 | |||
| Other assets | 886 | |||
| Total assets | 20,235 | |||
| Accounts payable | 127 | |||
| Accrued compensation | 1,271 | |||
| Accrued research and development expenses | 82 | |||
| Deferred revenue | 716 | |||
| Liability related to the sale of future revenues - current portion | 9,750 | |||
| Other current liabilities | 2,976 | |||
| Total current liabilities | 14,922 | |||
| Operating lease liabilities - long-term | 9,347 | |||
| Liability related to the sale of future revenues - long-term | 32,673 | |||
| Other long-term liabilities | 1,795 | |||
| Total liabilities | 58,737 | |||
| Common stock - 0.0001 par value, 500,000 shares authorized as of december 31, 2025 and 2024, respectively 7,324 and 5,859 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 1 | |||
| Additional paid-in capital | 1,983,361 | |||
| Accumulated other comprehensive income | 1 | |||
| Accumulated deficit | -2,021,865 | |||
| Total stockholders' equity (deficit) | -38,502 | |||
| Total liabilities and stockholders' equity (deficit) | 20,235 | |||
Atara Biotherapeutics, Inc. (ATRA)
Atara Biotherapeutics, Inc. (ATRA)